-
About Me
Alison Bass is a Pulitzer Prize nominee and author of Side Effects: A Prosecutor, a Whistleblower and a Bestselling Antidepressant on Trial, which won the NASW Science in Society Award. She was a longtime medical and science writer for The Boston Globe and has also written for The Miami Herald, Psychology Today and MIT's Technology Review, among other publications. A series she wrote for The Boston Globe on psychiatry was nominated for a Pulitzer Prize and she has received many other journalism awards. In 2007, she won a prestigious Alicia Patterson Fellowship to write Side Effects. Bass teaches journalism at Mount Holyoke College and Brandeis University.
Tag Archives: Department of Justice
Calls for action against authors of controversial Paxil study are getting louder
Share In the wake of GlaxoSmithKline’s record-breaking $3 billion settlement with the U.S. Department of Justice, a number of psychiatrists and researchers have redoubled their efforts to get Paxil study 329 retracted. As mentioned here and in other news accounts, the … Continue reading
Posted in antidepressants, clinical trials, conflicts of interest, drug marketing, ghostwriting, National Institutes of Health, pharmaceutical industry, scientific journal retractions, scientific misconduct, university industry collaboration
Tagged antidepressants, Brown University, Department of Justice, GlaxoSmithKline, Health Care Renewal, Martin Keller, oneboringoldman, Paxil
2 Comments
Why academic researchers involved in fraudulent Paxil study escape scrutiny
Share The Chronicle of Higher Education this week ponders why various universities have taken no action against the academic researchers who co-authored the notorious Paxil study that formed the crux of GlaxoSmithKline’s recent $3 billion settlement with the Department of … Continue reading
Posted in antidepressants, clinical trials, National Institutes of Health, pharmaceutical industry, scientific journal retractions, scientific misconduct, university industry collaboration
Tagged Brown University, Chronicle of Higher Education, Department of Justice, GlaxoSmithKline, Martin Keller, Paxil
3 Comments